Germany's largest pharmaceutical company Boehringer Ingelheim on Wednesday reported a currency-adjusted 6.1% gain in 2024 ...

Boehringer Laboratory Illustrative image Number of patients reached in 2024 jumps 8% to 66 million R&D investments rise to ...

Germany's largest pharma company, today reported a currency-adjusted 6.1% gain in full-year 2024 revenues, buoyed by its ...

With counterfeit drugs making up 30% of global sales, regulators are tightening serialisation and labelling rules to secure ...

Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and guidance for this year. | Boehringer Ingelheim picked a challenging day to reveal its 2024 financial results and ...

Having a blueprint for supply chain resiliency is critical, as a mature and robust risk programme enables the right emergency ...

The prevalence of metabolic dysfunction–associated steatotic liver disease, chronic kidney disease, and obstructive sleep ...

Elon Musk retains the top spot in Forbes’ Billionaires List 2025, with 288 fresh faces joining the rankings. See the newest ...

Discover March 2025’s top biotech deals, featuring major collaborations in small molecules, bispecific antibodies and protein ...

Reducing levels of LDL-cholesterol can reduce the risk of dementia by 26%, according to a new study, which also suggests ...

The five youngest billionaires in the world this year, all heirs to their fortunes, collectively hold US$18.1 billion in wealth, according to Forbes’ latest annual ranking.

First VISTA Inhibitor Drug Approval By 2028 Says Kuick Research In New Research Publication. Delhi, April 02, 2025 (GLOBE ...